82_FR_17078 82 FR 17012 - Preparation for International Cooperation on Cosmetics Regulation Eleventh Annual Meeting; Public Meeting

82 FR 17012 - Preparation for International Cooperation on Cosmetics Regulation Eleventh Annual Meeting; Public Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 82, Issue 66 (April 7, 2017)

Page Range17012-17013
FR Document2017-06938

The Food and Drug Administration (FDA or we) is announcing a public meeting entitled ``International Cooperation on Cosmetics Regulation (ICCR)--Preparation for ICCR-11 Meeting.'' The purpose of the meeting is to invite public input on various topics pertaining to the regulation of cosmetics. We may use this input to help us prepare for the ICCR-11 meeting that will be held July 12-14, 2017, in Brasilia, Brazil.

Federal Register, Volume 82 Issue 66 (Friday, April 7, 2017) 
[Federal Register Volume 82, Number 66 (Friday, April 7, 2017)]
[Notices]
[Pages 17012-17013]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-06938]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-0001]


Preparation for International Cooperation on Cosmetics Regulation 
Eleventh Annual Meeting; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing a 
public meeting entitled ``International Cooperation on Cosmetics 
Regulation (ICCR)--Preparation for ICCR-11 Meeting.'' The purpose of 
the meeting is to invite public input on various topics pertaining to 
the regulation of cosmetics. We may use this input to

[[Page 17013]]

help us prepare for the ICCR-11 meeting that will be held July 12-14, 
2017, in Brasilia, Brazil.

DATES: The public meeting will be held on May 25, 2017, from 2 p.m. to 
4 p.m. See the SUPPLEMENTARY INFORMATION section for registration date 
and information.

ADDRESSES: The public meeting will be held at the Food and Drug 
Administration, Center for Food Safety and Applied Nutrition, 5001 
Campus Dr., Wiley Auditorium (first floor), College Park, MD 20740.

FOR FURTHER INFORMATION CONTACT: Jonathan Hicks, Office of Cosmetics 
and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS-125), 
College Park, MD 20740, email: [email protected], 240-402-
1375.

SUPPLEMENTARY INFORMATION:

I. Background

    The purpose of the multilateral framework on the ICCR is to pave 
the way for the removal of regulatory obstacles to international trade 
while maintaining global consumer protection. The purpose of the 
meeting is to invite public input on various topics pertaining to the 
regulation of cosmetics. We may use this input to help us prepare for 
the ICCR-11 meeting that will be held July 12-14, 2017, in Brasilia, 
Brazil.
    ICCR is a voluntary international group of cosmetics regulatory 
authorities from Brazil, Canada, the European Union, Japan, and the 
United States of America. These regulatory authority members will enter 
into constructive dialogue with their relevant cosmetics industry trade 
associations and public advocacy groups. Currently, the ICCR members 
are: The Brazilian Health Surveillance Agency; Health Canada; the 
European Commission Directorate-General for Internal Market, Industry, 
Entrepreneurship, and Small and Medium-sized Enterprises; the Ministry 
of Health, Labor, and Welfare of Japan; and FDA. All decisions made by 
consensus will be compatible with the laws, policies, rules, 
regulations, and directives of the respective administrations and 
governments. Members will implement and/or promote actions or documents 
within their own jurisdictions and seek convergence of regulatory 
policies and practices. Successful implementation will need input from 
stakeholders.

II. Topics for Discussion at the Public Meeting

    We will make the agenda for the public meeting available on the 
Internet at http://www.fda.gov/Cosmetics/InternationalActivities/ICCR/default.htm. Depending on the number of requests for oral 
presentations, we intend to have an agenda available by May 18, 2017.

III. Participating in the Public Meeting

    Registration: To register for the public meeting, send registration 
information (including your name, title, affiliation, address, email, 
and telephone), to Jonathan Hicks by May 11, 2017. If you would like to 
listen to the meeting by phone, please submit a request for a dial-in 
number by May 11, 2017. If you need special accommodations due to a 
disability, please contact Jonathan Hicks by May 18, 2016.
    Requests for Oral Presentations: If you wish to make an oral 
presentation, you should notify Jonathan Hicks by May 11, 2017, and 
submit a brief statement of the general nature of the evidence or 
arguments that you wish to present, your name, title, affiliation, 
address, email, and telephone, and indicate the approximate amount of 
time you need to make your presentation. You may present proposals for 
future ICCR agenda items, data, information, or views, in person or in 
writing, on issues pending at the public meeting. There will be no 
presentations by phone. Time allotted for oral presentations may be 
limited to 10 minutes or less for each presenter.
    Transcripts: Please be advised that as soon as a transcript of the 
public meeting is available, it will be accessible at https://www.regulations.gov. It may also be viewed at the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20850.

    Dated: April 3, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-06938 Filed 4-6-17; 8:45 am]
 BILLING CODE 4164-01-P

17012 Federal Register / Vol. 82, No. 66 / Friday, April 7, 2017 / Notices Management, FDA will post your FOR FURTHER INFORMATION CONTACT: approximate time requested to make comment, as well as any attachments, Lauren D. Tesh, Center for Drug their presentation on or before April 7, except for information submitted, Evaluation and Research, Food and 2017. Time allotted for each marked and identified, as confidential, Drug Administration, 10903 New presentation may be limited. If the if submitted as detailed in Hampshire Ave., Bldg. 31, rm. 2417, number of registrants requesting to ‘‘Instructions.’’ Silver Spring, MD 20993–0002, 301– speak is greater than can be reasonably Instructions: All submissions received 796–9001, FAX: 301–847–8533, accommodated during the scheduled AMDAC@fda.hhs.gov, or FDA Advisory open public hearing session, FDA may must include the Docket No. FDA– Committee Information Line, 1–800– conduct a lottery to determine the 2017–N–1813 for ‘‘Antimicrobial Drugs 741–8138 (301–443–0572 in the speakers for the scheduled open public Advisory Committee; Notice of Meeting; Washington, DC area). A notice in the hearing session. The contact person will Establishment of a Public Docket; Federal Register about last minute notify interested persons regarding their Request for Comments.’’ Received modifications that impact a previously request to speak by April 10, 2017. comments will be placed in the docket Persons attending FDA’s advisory and, except for those submitted as announced advisory committee meeting cannot always be published quickly committee meetings are advised that the ‘‘Confidential Submissions,’’ publicly Agency is not responsible for providing enough to provide timely notice. viewable at https://www.regulations.gov access to electrical outlets. Therefore, you should always check the or at the Division of Dockets FDA welcomes the attendance of the Agency’s Web site at http:// Management between 9 a.m. and 4 p.m., public at its advisory committee www.fda.gov/AdvisoryCommittees/ Monday through Friday. meetings and will make every effort to default.htm and scroll down to the • Confidential Submissions—To appropriate advisory committee meeting accommodate persons with disabilities. submit a comment with confidential link, or call the advisory committee If you require accommodations due to a information that you do not wish to be information line to learn about possible disability, please contact Lauren D. Tesh made publicly available, submit your modifications before coming to the at least 7 days in advance of the comments only as a written/paper meeting. meeting. submission. You should submit two FDA is committed to the orderly SUPPLEMENTARY INFORMATION conduct of its advisory committee copies total. One copy will include the Agenda: The committee will discuss information you claim to be confidential meetings. Please visit our Web site at the development of antibacterial drugs http://www.fda.gov/Advisory with a heading or cover note that states that treat a single species of bacteria ‘‘THIS DOCUMENT CONTAINS Committees/AboutAdvisoryCommittees/ when the target species infrequently ucm111462.htm for procedures on CONFIDENTIAL INFORMATION.’’ The causes infections; examples of such Agency will review this copy, including public conduct during advisory drugs include those that are only active committee meetings. the claimed confidential information, in against Pseudomonas aeruginosa or its consideration of comments. The Notice of this meeting is given under Acinetobacter baumannii. the Federal Advisory Committee Act (5 second copy, which will have the FDA intends to make background claimed confidential information U.S.C. app. 2). material available to the public no later redacted/blacked out, will be available than 2 business days before the meeting. Dated: April 3, 2017. for public viewing and posted on If FDA is unable to post the background Janice M. Soreth, https://www.regulations.gov. Submit material on its Web site prior to the Associate Commissioner for Special Medical both copies to the Division of Dockets meeting, the background material will Programs. Management. If you do not wish your be made publicly available at the [FR Doc. 2017–06901 Filed 4–6–17; 8:45 am] name and contact information to be location of the advisory committee BILLING CODE 4164–01–P made publicly available, you can meeting, and the background material provide this information on the cover will be posted on FDA’s Web site after sheet and not in the body of your the meeting. Background material is DEPARTMENT OF HEALTH AND comments and you must identify this available at http://www.fda.gov/ HUMAN SERVICES information as ‘‘confidential.’’ Any AdvisoryCommittees/Calendar/ information marked as ‘‘confidential’’ Food and Drug Administration default.htm. Scroll down to the will not be disclosed except in appropriate advisory committee meeting [Docket No. FDA–2017–N–0001] accordance with 21 CFR 10.20 and other link. applicable disclosure law. For more Procedure: Interested persons may Preparation for International information about FDA’s posting of present data, information, or views, Cooperation on Cosmetics Regulation comments to public dockets, see 80 FR orally or in writing, on issues pending Eleventh Annual Meeting; Public 56469, September 18, 2015, or access before the committee. All electronic and Meeting the information at: https://www.gpo.gov/ written submissions submitted to the fdsys/pkg/FR-2015-09-18/pdf/2015- AGENCY: Food and Drug Administration, Docket (see the ADDRESSES section) on HHS. 23389.pdf. or before April 10, 2017, will be ACTION: Notice of public meeting. Docket: For access to the docket to provided to the committee. Oral read background documents or the presentations from the public will be SUMMARY: The Food and Drug electronic and written/paper comments scheduled between approximately 1:30 Administration (FDA or we) is received, go to https:// p.m. and 2:30 p.m. Those individuals announcing a public meeting entitled nlaroche on DSK30NT082PROD with NOTICES www.regulations.gov and insert the interested in making formal oral ‘‘International Cooperation on docket number, found in brackets in the presentations should notify the contact Cosmetics Regulation (ICCR)— heading of this document, into the person and submit a brief statement of Preparation for ICCR–11 Meeting.’’ The ‘‘Search’’ box and follow the prompts the general nature of the evidence or purpose of the meeting is to invite and/or go to the Division of Dockets arguments they wish to present, the public input on various topics Management, 5630 Fishers Lane, rm. names and addresses of proposed pertaining to the regulation of 1061, Rockville, MD 20852. participants, and an indication of the cosmetics. We may use this input to VerDate Sep<11>2014 14:52 Apr 06, 2017 Jkt 241001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 E:\FR\FM\07APN1.SGM 07APN1

Federal Register / Vol. 82, No. 66 / Friday, April 7, 2017 / Notices 17013 help us prepare for the ICCR–11 meeting at http://www.fda.gov/Cosmetics/ Effective Date: April 7, 2017. that will be held July 12–14, 2017, in InternationalActivities/ICCR/ Applicability Date: The correction Brasilia, Brazil. default.htm. Depending on the number notice is applicable for the Findings of DATES: The public meeting will be held of requests for oral presentations, we Research Misconduct notice published on May 25, 2017, from 2 p.m. to 4 p.m. intend to have an agenda available by on June 8, 2016. See the SUPPLEMENTARY INFORMATION May 18, 2017. FOR FURTHER INFORMATION CONTACT: Ms. section for registration date and Karen Gorirossi at 240–453–8800. III. Participating in the Public Meeting information. SUPPLEMENTARY INFORMATION: Registration: To register for the public ADDRESSES: The public meeting will be I. Background meeting, send registration information held at the Food and Drug (including your name, title, affiliation, In FR Doc. 2016–13541 of June 8, Administration, Center for Food Safety address, email, and telephone), to 2016 (81 FR 36932–36933), there was a and Applied Nutrition, 5001 Campus Jonathan Hicks by May 11, 2017. If you typographical error involving one of the Dr., Wiley Auditorium (first floor), would like to listen to the meeting by papers cited in the notice. The error is College Park, MD 20740. phone, please submit a request for a identified and corrected in the FOR FURTHER INFORMATION CONTACT: dial-in number by May 11, 2017. If you Correction of Errors section below. Jonathan Hicks, Office of Cosmetics and need special accommodations due to a Colors, Food and Drug Administration, disability, please contact Jonathan Hicks II. Correction of Errors 5001 Campus Dr. (HFS–125), College by May 18, 2016. In FR Doc. 2016–13541 of June 8, Park, MD 20740, email: jonathan.hicks@ Requests for Oral Presentations: If you 2016 (81 FR 36932–36933), make the fda.hhs.gov, 240–402–1375. wish to make an oral presentation, you following correction: SUPPLEMENTARY INFORMATION: should notify Jonathan Hicks by May 1. On page 36932, third column, in FR I. Background 11, 2017, and submit a brief statement Doc. 2016–13541, second to last of the general nature of the evidence or paragraph, line 5, change ‘‘August’’ to The purpose of the multilateral arguments that you wish to present, ‘‘December’’ so that the text reads framework on the ICCR is to pave the your name, title, affiliation, address, ‘‘falsified twenty-four (24) fluorescent way for the removal of regulatory email, and telephone, and indicate the image panels by drawing staining in obstacles to international trade while approximate amount of time you need Photoshop and falsely labeling them in maintaining global consumer protection. to make your presentation. You may Figures 5B, 5C, 5D, 5E, 7A, 7B, 7D, 8A, The purpose of the meeting is to invite present proposals for future ICCR 8B, 9A, and 9B in the December 2015 public input on various topics agenda items, data, information, or Development paper and included some pertaining to the regulation of views, in person or in writing, on issues of the same images in four (4) figures in cosmetics. We may use this input to pending at the public meeting. There the ASCB 2015 poster and in two (2) help us prepare for the ICCR–11 meeting will be no presentations by phone. Time figures in the MARZ 2015 poster’’ that will be held July 12–14, 2017, in allotted for oral presentations may be Dated: March 30, 2017. Brasilia, Brazil. limited to 10 minutes or less for each ICCR is a voluntary international Kathryn Partin, presenter. group of cosmetics regulatory Director, Office of Research Integrity. Transcripts: Please be advised that as authorities from Brazil, Canada, the soon as a transcript of the public [FR Doc. 2017–07006 Filed 4–6–17; 8:45 am] European Union, Japan, and the United meeting is available, it will be accessible BILLING CODE 4150–31–P States of America. These regulatory at https://www.regulations.gov. It may authority members will enter into also be viewed at the Division of constructive dialogue with their Dockets Management (HFA–305), Food DEPARTMENT OF HEALTH AND relevant cosmetics industry trade and Drug Administration, 5630 Fishers HUMAN SERVICES associations and public advocacy Lane, Rm. 1061, Rockville, MD 20850. groups. Currently, the ICCR members National Institutes of Health Dated: April 3, 2017. are: The Brazilian Health Surveillance Office of the Director, National Agency; Health Canada; the European Leslie Kux, Associate Commissioner for Policy. Institutes of Health; Notice of Meeting Commission Directorate-General for Internal Market, Industry, [FR Doc. 2017–06938 Filed 4–6–17; 8:45 am] Pursuant to section 10(d) of the Entrepreneurship, and Small and BILLING CODE 4164–01–P Federal Advisory Committee Act, as Medium-sized Enterprises; the Ministry amended (5 U.S.C. Appendix 2), notice of Health, Labor, and Welfare of Japan; is hereby given of the meeting of the and FDA. All decisions made by DEPARTMENT OF HEALTH AND Council of Councils. consensus will be compatible with the HUMAN SERVICES The meeting will be open to the laws, policies, rules, regulations, and public as indicated below, with directives of the respective Office of the Secretary attendance limited to space available. administrations and governments. Individuals who plan to attend and Findings of Research Misconduct; Members will implement and/or need special assistance, such as sign Correction promote actions or documents within language interpretation or other their own jurisdictions and seek AGENCY: Office of the Secretary, HHS. reasonable accommodations, should convergence of regulatory policies and ACTION: Correction of notice. notify the Contact Person listed below nlaroche on DSK30NT082PROD with NOTICES practices. Successful implementation in advance of the meeting. The open will need input from stakeholders. SUMMARY: This document corrects an session will be videocast and can be error that appeared in the notice accessed from the NIH Videocasting and II. Topics for Discussion at the Public published in the June 8, 2016, Federal Podcasting Web site (http:// Meeting Register entitled ‘‘Findings of Research videocast.nih.gov). We will make the agenda for the Misconduct.’’ A portion of the meeting will be public meeting available on the Internet DATES: closed to the public in accordance with VerDate Sep<11>2014 14:52 Apr 06, 2017 Jkt 241001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\07APN1.SGM 07APN1


Document Created: 2017-04-06 23:49:30
Document Modified: 2017-04-06 23:49:30
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of public meeting.
DatesThe public meeting will be held on May 25, 2017, from 2 p.m. to 4 p.m. See the SUPPLEMENTARY INFORMATION section for registration date and information.
ContactJonathan Hicks, Office of Cosmetics and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS-125), College Park, MD 20740, email: [email protected], 240-402- 1375.
FR Citation82 FR 17012 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR